Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $12.4500 (-4.82%) ($11.9900 - $13.4400) on Tue. Mar. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.09% (three month average) | RSI | 39 | Latest Price | $12.4500(-4.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -7.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(49%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -2.045% in a week (0% probabilities). VIXM(-37%) VXX(-36%) TLT(-11%) UNG(-7%) UUP(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.045% (StdDev 4.09%) | Hourly BBV | 0 () | Intraday Trend | -4.2% | | | |
|
1 - 5 Day Possible Target | $-4.58(-136.79%) | Resistance Level | $13.28 | 5 Day Moving Average | $12.07(3.15%) | 10 Day Moving Average | $12.44(0.08%) | 20 Day Moving Average | $13.28(-6.25%) | To recent high | -30% | To recent low | 12% | Market Cap | $925m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |